Benign Prostate Hyperplasia
Conditions
Interventions
Exposed group (finasteride 5mg qd and Tamsulosin 0.2mg qd) + Lingze tablet 4 tablets tid):None
non-exposed group (finasteride 5mg qd and Tamsulosin 0.2mg qd):None
Sponsors
The Affiliated Hospital of Hangzhou Normal University
Eligibility
Sex/Gender
Male
Age
50 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Meet the benign prostatic hyperplasia diagnostic criteria; (2) Age 50-90 years old; (3) No drug treatment related to prostatic hyperplasia 4 weeks before treatment; (4) Treated with simple western medicine (finasteride 5 mg, 1 time/day and the new 0.2 mg, 1 time/night) or combined Chinese and western medicine treatment, on the basis of western medicine treatment, and with the spirit ze, 4 / time, 3 times/day); (5) Complete medical records and treatment conformed to the retrospective cohort study design.
Exclusion criteria
Exclusion criteria: (1) Urinary stones; (2) The existence of urinary tract infection; (3) Presence of prostate or bladder tumors; (4) The urethral stricture; (5) Neurogenic bladder; (6) Of genitourinary tuberculosis; (7) Previous history of prostate surgery; (8) 2 weeks with transurethral examination or surgery history;; (9) Complicated with other serious primary diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Prostate Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life index score; | — |
Countries
China
Contacts
Public ContactZhao Xudong
The Affiliated Hospital of Hangzhou Normal University
Outcome results
None listed